Nat. Rev. Cardiol. doi: /nrcardio

Slides:

Advertisements

Similar presentations

Acute Non-Q Wave Cocaine-related Myocardial Infarction

Advertisements

Nat. Rev. Cardiol. doi: /nrcardio

Laszlo Littmann, MD, PhD The American Journal of Medicine

Figure 2 Different manifestations of myocardial ischaemia

Nat. Rev. Cardiol. doi: /nrcardio

Figure 4 Pharmacodynamic comparison of crushed versus integral

Figure 4 BMI and mortality in patients with heart failure

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Global rates of sodium, fruit, and vegetable intake

Figure 3 Imaging characteristics of cardiac myxoma

Figure 1 Mechanism of thrombus formation during ST-segment

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Ischaemic outcomes in the ST-segment elevation myocardial

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Management of acute coronary syndrome with intact fibrous cap

Figure 1 Underreporting of treatment-related toxicities by physicians, relative to patients with either advanced-stage lung cancer, or early-stage breast.

Section A: Introduction

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Ischaemic and bleeding outcomes in the major clinical trials

Figure 5 Proposed clinical approach in athletes

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Health-care system today

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Cardiovascular risk and disease across the life-course

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 PCI strategies in patients with STEMI and multivessel disease

Nat. Rev. Cardiol. doi: /nrcardio

Laszlo Littmann, MD, PhD The American Journal of Medicine

Figure 1 Decision tree integrating the assessment,

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Global cost of HF per capita in 2012

Figure 5 Examples of biomarker-guided trials

Figure 1 Manual thrombus aspiration

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Milestones in coronary angioplasty

Figure 3 Challenges for big data applications in cardiovascular care

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 4 Observational studies on multiple treatment strategies

Nat. Rev. Cardiol. doi: /nrcardio

Mancini JG, et al. Am J Cardiol.

Figure 6 The neurogenic components of angina

Nat. Rev. Cardiol. doi: /nrcardio

Prakash Harikrishnan et al. JACEP 2015;1:

Figure 1 Essential features and goals of a precision medicine system

Flow chart of the study population according to thienopyridines used in the FAST-MI registry in patients with STEMI and NSTEMI. FAST-MI, French Registry.

Figure 1 Ischaemic conditioning

Nat. Rev. Cardiol. doi: /nrcardio

Figure 4 Electrocardiogram patterns associated with Brugada syndrome

Figure 2 Impaired mitochondrial capacity and function in heart failure

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Any, acute and subacute stent thrombosis with bivalirudin versus unfractionated heparin (UFH) in predominantly ST segment elevation myocardial infarction.

Major bleeding with bivalirudin versus unfractionated heparin (UFH) in predominantly ST segment elevation myocardial infarction (STEMI) studies; (A) glycoprotein.

A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.

(Case 5) Left ventricular hypertrophy—12-lead ECG demonstrating NSR with LVH. The ST segment depression in the lateral leads (I, aVl, V5, and V6) is seen.

12 lead ECG demonstrating ST segment elevation and prominent Q waves in the anterior distribution. 12 lead ECG demonstrating ST segment elevation and prominent.

Non-ST segment elevation AMI—AMI characteristically presents with STE in approximately 50% of myocardial infarction patients; in the remainder of the AMI.

(Case 3) Acute, isolated posterior wall myocardial infarction.

Distribution of left atrial (LA) remodel.

Presentation transcript:

Nat. Rev. Cardiol. doi:10.1038/nrcardio.2015.165 Figure 2 Practice, delays, and improvements in diagnosis and treatment of STEMI Figure 2 | Practice, delays, and improvements in diagnosis and treatment of STEMI. The current pathway of care for outpatient STEMI contains several features that lead to improved outcomes relative to inpatient STEMI. Sources of delay in the care of inpatient STEMI can result from patient characteristics and from the lack of appropriate systems outside of the emergency medicine setting. Improvements in the care of inpatient STEMI can reduce the times taken for diagnosis and appropriate treatment. Abbreviations: ECG, electrocardiogram; STEMI, ST-segment elevation myocardial infarction. Stouffer, G. A. et al. (2015) Predictors, treatment, and outcomes of STEMI occurring in hospitalized patients Nat. Rev. Cardiol. doi:10.1038/nrcardio.2015.165